Ethical Considerations in eDiscovery: Rules and Responsibilities 2021

Leeanne manages all aspects of national and international discovery. She frequently serves as eDiscovery counsel on large-scale litigations. Her experience includes crafting and overseeing defense discovery strategy for matters with complex discovery issues. She frequently negotiates eDiscovery orders, drafts and argues discovery motions, and prepares and defends witnesses on eDiscovery-related topics. She formulates efficient and effective workflows for all phases of document collection, review and production, utilizing advanced technologies. Leeanne addresses clients' eDiscovery issues in both litigation and pre-litigation settings. Leeanne frequently speaks on eDiscovery-related topics.

Further, Leeanne advises on policies and procedures related to information management, including records management and defensible deletion projects. Leeanne frequently holds training seminars on these topics.

Leeanne's background is in complex litigation representing companies in the life-sciences sector in mass torts litigation, commercial disputes and investigations.

Leeanne regularly participates in the firm's recruiting efforts and is an active member of the firm's Leadership Alliance for Women (LAW). Pro bono is part of Leeanne's practice and she dedicates significant time to assisting people and communities in need.

Ian Dwyer has experience in environmental litigation and litigation support with a particular emphasis in the management of electronic databases and the presentation of trial exhibits and deposition testimony. Prior to joining Everlaw, Ian attended the University of California, Berkeley.

Kelly Clay is Assistant General Counsel of the Legal Department for GlaxoSmithKline, based in RTP, North Carolina. She has been with GSK for many years as Merits Counsel on electronic discovery and discovery process management. Kelly is a member of GSK’s Dispute Resolution & Prevention group, and oversees numerous domestic and international matters involving GSK